Skip to search formSkip to main contentSkip to account menu

intoplicine

Known as: intoplicin, 7H-Benzo(e)pyrido(4,3-b)indol-3-ol, 11-((3-(dimethylamino)propyl)amino)-8-methyl-, 7H-benzo(e)pyrido(4,3-b)indol-3-ol, 11-((3-(dimethylamino)propyl)amino)-8-methyl 
A benzopyridoindole derivative with antineoplastic property. Intoplicine inhibits activities of both topoisomerase I and II via intercalating DNA… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
Cancer of unknown primary origin is the eighth most common form of malignancy and accounts for up to 10% of all neoplasms… 
1997
1997
Low light level fluorescence microscopy studies have been carried out on MCF7‐P human mammary tumor cells to localize the… 
1994
1994
BACKGROUND Intoplicine (RP60475) is the most active analogue evaluated in the 7H-benzo[e]-pyrido-[4,3-b]-indole series of… 
1993
1993
SummaryIntoplicine (RP 60475, NSC 645008) is a new 7H-benzo[e]pyrido[4,3-b] indole derivative which interacts with DNA and…